Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancrelipase delayed-release capsules for maldigestion in exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy
2007-004004-12Phase 3Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in exocrine pancreatic insufficiency (EPI) and chronic pancreatitis (CP) comparing Pancrelipase delayed-release capsules with Placebo (2 arms). Primary endpoint: Change in coefficient of fat absorption. Started Feb 2008; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2007-004004-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004004-12.